Covenant Multifamily Offices’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$1.2M Buy
5,663
+695
+14% +$160K 0.22% 78
2021
Q2
$1.21M Buy
4,968
+2,189
+79% +$539K 0.22% 78
2021
Q1
$691K Buy
2,779
+1,881
+209% +$449K 0.14% 90
2020
Q4
$206K Sell
898
-46
-5% -$10.6K 0.04% 131
2020
Q3
$240K Sell
944
-873
-48% -$216K 0.05% 107
2020
Q2
$429K Buy
+1,817
New +$415K 0.08% 97
2019
Q3
Sell
-1,347
Closed -$248K 141
2019
Q2
$248K Buy
+1,347
New +$241K 0.05% 131

Other funds holding AMGN

Covenant Multifamily Offices's AMGN Position: Q3 2021 in Review

Covenant Multifamily Offices increased its Amgen (AMGN) stake by 14% in Q3 2021, buying an estimated $160K and bringing the position to 5,663 shares worth $1.2M. The position accounts for 0.22% of the portfolio, ranked #78.

Covenant Multifamily Offices first reported a position in AMGN in Q2 2019 and has held it in 7 quarters since. The position peaked at $1.21M in Q2 2021. 2,132 funds tracked by Wall St. Rank hold AMGN as of Q3 2021.

  • Covenant Multifamily Offices held 5,663 shares of Amgen worth $1.2M as of Q3 2021.
  • Covenant Multifamily Offices bought 695 Amgen shares in Q3 2021, an estimated $160K.
  • Amgen made up 0.22% of Covenant Multifamily Offices's portfolio in Q3 2021, its #78 holding.
  • Covenant Multifamily Offices first reported a position in Amgen in Q2 2019 and has held it in 7 quarters since.
  • Covenant Multifamily Offices's Amgen position peaked at $1.21M in Q2 2021.
  • 2,132 funds tracked by Wall St. Rank held Amgen as of Q3 2021.

Based on Covenant Multifamily Offices's 13F filing for Q3 2021, filed 21 Oct 2021.